Daily life mobility detects frailty, falls, and functioning in ADT-treated prostate cancer survivors.
Kerri M Winters-StoneDeanne TibbittsMartina ManciniSydnee StoylesNathan DieckmannJulie GraffMahmoud El-GoharyFay HorakPublished in: Research square (2024)
Continuous passive monitoring of daily life mobility may identify prostate cancer survivors who have or are developing risk for frailty, falls, and declines in physical functioning.